<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37052263</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-1246</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of attention disorders</Title><ISOAbbreviation>J Atten Disord</ISOAbbreviation></Journal><ArticleTitle>Successful Treatment of Post-COVID-19 ADHD-like Syndrome: A Case Report.</ArticleTitle><Pagination><StartPage>1092</StartPage><EndPage>1098</EndPage><MedlinePgn>1092-1098</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/10870547231168338</ELocationID><Abstract><AbstractText>Despite inattention being one of the most common symptoms of Post-COVID-19 Syndrome (PCS), there is a gap in the literature regarding its treatment. This report presents a case of attentional symptoms and fatigue that emerged after the SARS-CoV-2 infection. The symptoms were similar to ADHD in adults, although the 61-year-old patient had never experienced inattention symptoms before. The patient was initially treated with Methylphenidate and then Lisdexamfetamine. Both were adapted to the needs and treatment response presented by the patient. After several changes in the therapeutic regimen, including the addition of Bupropion, the patient achieved remission of his symptoms. This case highlights the importance of treating PCS inattention and fatigue as an ADHD-like syndrome, despite the evident different etiology of symptoms. It would be necessary to replicate these findings to confirm our results, thus benefiting other patients currently affected by this syndrome.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Victor</LastName><ForeName>Marcelo Moraes</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Federal University of Rio Grande do Sul, Porto Alegre Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xfc;ller Haas</LastName><ForeName>Let&#xed;cia</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-6570-981X</Identifier><AffiliationInfo><Affiliation>Federal University of Rio Grande do Sul, Porto Alegre Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grevet</LastName><ForeName>Eugenio Hor&#xe1;cio</ForeName><Initials>EH</Initials><AffiliationInfo><Affiliation>Federal University of Rio Grande do Sul, Porto Alegre Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rohde</LastName><ForeName>Lu&#xed;s Augusto</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Federal University of Rio Grande do Sul, Porto Alegre Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute of Developmental Psychiatry for Children and Adolescents (CNPq), Sao Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UniEduK, Jaguari&#xfa;na, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Atten Disord</MedlineTA><NlmUniqueID>9615686</NlmUniqueID><ISSNLinking>1087-0547</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000697">Central Nervous System Stimulants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001289" MajorTopicYN="Y">Attention Deficit Disorder with Hyperactivity</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000697" MajorTopicYN="Y">Central Nervous System Stimulants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ADHD</Keyword><Keyword MajorTopicYN="N">Brain Fog</Keyword><Keyword MajorTopicYN="N">Long Covid</Keyword><Keyword MajorTopicYN="N">Post-COVID-19 Syndrome</Keyword><Keyword MajorTopicYN="N">case report</Keyword><Keyword MajorTopicYN="N">treatment</Keyword></KeywordList><CoiStatement>The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: EHG was on the speaker's bureau for Shire for the last three years. LAR has received grant or research support from, served as a consultant to, and served on the speakers' bureau of Abbott, Ach&#xe9;, Bial, Medice, Novartis/Sandoz, Pfizer/Upjohn, and Shire/Takeda in the last 3 years. The ADHD and Juvenile Bipolar Disorder Outpatient Programs chaired by Dr Rohde have received unrestricted educational and research support from the following pharmaceutical companies in the last 3 years: Novartis/Sandoz and Shire/Takeda. Dr Rohde has received authorship royalties from Oxford Press and ArtMed. MMV and LMH declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>13</Day><Hour>7</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37052263</ArticleId><ArticleId IdType="pmc">PMC10102822</ArticleId><ArticleId IdType="doi">10.1177/10870547231168338</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders: DSM-V (5th). Author.</Citation></Reference><Reference><Citation>Anbarasan D., Kitchin M., Adler L. A. (2020). Screening for adult ADHD. Current Psychiatry Reports, 22, 72. 10.1007/s11920-020-01194-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11920-020-01194-9</ArticleId><ArticleId IdType="pubmed">33095375</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker J. H., Lin J. J., Doernberg M., Stone K., Navis A., Festa J. R., Wisnivesky J. P. (2021). Assessment of cognitive function in patients after COVID-19 infection. JAMA network open, 4(10), e2130645. 10.1001/jamanetworkopen.2021.30645</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.30645</ArticleId><ArticleId IdType="pmc">PMC8536953</ArticleId><ArticleId IdType="pubmed">34677597</ArticleId></ArticleIdList></Reference><Reference><Citation>Belloni S., Arrigoni C., de Sanctis R., Arcidiacono M. A., Dellafiore F., Caruso R. (2021). A systematic review of systematic reviews and pooled meta-analysis on pharmacological interventions to improve cancer-related fatigue. Critical Reviews in Oncology/Hematology, 166, 103373. 10.1016/j.critrevonc.2021.103373</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.critrevonc.2021.103373</ArticleId><ArticleId IdType="pubmed">34051301</ArticleId></ArticleIdList></Reference><Reference><Citation>Brevik E. J., Lundervold A. J., Haavik J., Posserud M. B. (2020). Validity and accuracy of the adult attention-deficit/hyperactivity disorder (ADHD) self-report scale (ASRS) and the Wender Utah Rating Scale (WURS) symptom checklists in discriminating between adults with and without ADHD. Brain and Behavior, 10(6), e01605. 10.1002/brb3.1605</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.1605</ArticleId><ArticleId IdType="pmc">PMC7303368</ArticleId><ArticleId IdType="pubmed">32285644</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F., Ling S., Lui L. M. W., Lee Y., Gill H., Teopiz K. M., Rodrigues N. B., Subramaniapillai M., Di Vincenzo J. D., Cao B., Lin K., Mansur R. B., Ho R. C., Rosenblat J. D., Miskowiak K. W., Vinberg M., Maletic V., McIntyre R. S. (2022). Fatigue and cognitive impairment in Post-COVID-19 syndrome: A systematic review and meta-analysis. Brain, Behavior, and Immunity, 101, 93&#x2013;135. 10.1016/j.bbi.2021.12.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Crunfli F., Carregari V. C., Veras F. P., Silva L. S., Nogueira M. H., Antunes A. S. L. M., Vendramini P. H., Valen&#xe7;a A. G. F., Brand&#xe3;o-Teles C., Zuccoli G. D. S., Reis-de-Oliveira G., Silva-Costa L. C., Saia-Cereda V. M., Smith B. J., Codo A. C., de Souza G. F., Muraro S. P., Parise P. L., Toledo-Teixeira D. A., . . . Martins-de-Souza D. (2022). Morphological, cellular, and molecular basis of brain infection in COVID-19 patients. Proceedings of the National Academy of Sciences of the United States of America, 119(35), e2200960119. 10.1073/pnas.2200960119</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2200960119</ArticleId><ArticleId IdType="pmc">PMC9436354</ArticleId><ArticleId IdType="pubmed">35951647</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoogman M., Bralten J., Hibar D. P., Mennes M., Zwiers M. P., Schweren L., van Hulzen K., Medland S. E., Shumskaya E., Jahanshad N., Zeeuw P., Szekely E., Sudre G., Wolfers T., Onnink A., Dammers J. T., Mostert J. C., Vives-Gilabert Y., Kohls G., Franke B. (2017). Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults: A cross-sectional mega-analysis. The Lancet Psychiatry, 4(4), 310&#x2013;319. 10.1016/S2215-0366(17)30049-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(17)30049-4</ArticleId><ArticleId IdType="pmc">PMC5933934</ArticleId><ArticleId IdType="pubmed">28219628</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoogman M., Muetzel R., Guimaraes J. P., Shumskaya E., Mennes M., Zwiers M. P., Jahanshad N., Sudre G., Wolfers T., Earl E. A., Soliva Vila J. C., Vives-Gilabert Y., Khadka S., Novotny S. E., Hartman C. A., Heslenfeld D. J., Schweren L., Ambrosino S., Oranje B., . . . Franke B. (2019). Brain imaging of the cortex in ADHD: A coordinated analysis of large-scale clinical and population-based samples. American Journal of Psychiatry, 176(7), 531&#x2013;542. 10.1176/appi.ajp.2019.18091033</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ajp.2019.18091033</ArticleId><ArticleId IdType="pmc">PMC6879185</ArticleId><ArticleId IdType="pubmed">31014101</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain R., Jain S., Montano C. B. (2017). Addressing diagnosis and treatment gaps in adults with attention-deficit/Hyperactivity disorder. The Primary Care Companion For CNS Disorders, 19(5), 17nr02153. 10.4088/PCC.17nr02153</Citation><ArticleIdList><ArticleId IdType="doi">10.4088/PCC.17nr02153</ArticleId><ArticleId IdType="pubmed">28906602</ArticleId></ArticleIdList></Reference><Reference><Citation>Kao J., Frankland P. W. (2022). COVID fog demystified. Cell, 185(14), 2391&#x2013;2393. 10.1016/j.cell.2022.06.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.06.020</ArticleId><ArticleId IdType="pmc">PMC9197953</ArticleId><ArticleId IdType="pubmed">35768007</ArticleId></ArticleIdList></Reference><Reference><Citation>Kessler R. C., Adler L., Ames M., Demler O., Faraone S., Hiripi E., Howes M. J., Jin R., Secnik K., Spencer T., Ustun T. B., Walters E. E. (2005). The World Health Organization adult ADHD self-report scale (ASRS): A short screening scale for use in the general population. Psychological Medicine, 35(2), 245&#x2013;256. 10.1017/s0033291704002892</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s0033291704002892</ArticleId><ArticleId IdType="pubmed">15841682</ArticleId></ArticleIdList></Reference><Reference><Citation>Kooij S. J., Bejerot S., Blackwell A., Caci H., Casas-Brugu&#xe9; M., Carpentier P. J., Edvinsson D., Fayyad J., Foeken K., Fitzgerald M., Gaillac V., Ginsberg Y., Henry C., Krause J., Lensing M. B., Manor I., Niederhofer H., Nunes-Filipe C., Ohlmeier M. D., . . . Asherson P. (2010). European consensus statement on diagnosis and treatment of adult ADHD: The European network adult ADHD. BMC Psychiatry, 10(1), 67. 10.1186/1471-244X-10-67</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-244X-10-67</ArticleId><ArticleId IdType="pmc">PMC2942810</ArticleId><ArticleId IdType="pubmed">20815868</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P. A., Cuapio A., Villapol S. (2021). More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. medRxiv : the preprint server for health sciences. 01.27.21250617. 10.1101/2021.01.27.21250617</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.01.27.21250617</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Manu P. (2022). Repurposing drugs for Post-COVID-19 Fatigue Syndrome: methylphenidate, duloxetine, and brexpiprazole. American Journal of Therapeutics, 29(2), e229&#x2013;e230. 10.1097/MJT.0000000000001471</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MJT.0000000000001471</ArticleId><ArticleId IdType="pubmed">35389574</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattos P., Segenreich D., Saboya E., Louz&#xe3; M., Dias G., Romano M. (2006). Adapta&#xe7;&#xe3;o transcultural para o portugu&#xea;s da escala adult self-report scale para avalia&#xe7;&#xe3;o do transtorno de d&#xe9;ficit de aten&#xe7;&#xe3;o/hiperatividade (TDAH) em adultos. Archives of Clinical Psychiatry, 33(4), 188&#x2013;194. 10.1590/s0101-60832006000400004</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/s0101-60832006000400004</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirza S. A., Sheikh A. A. E., Barbera M., Ijaz Z., Javaid M. A., Shekhar R., Pal S., Sheikh A. B. (2022). COVID-19 and the endocrine system: A review of the current information and misinformation. Infectious Disease Reports, 14(2), 184&#x2013;197. 10.3390/idr14020023</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/idr14020023</ArticleId><ArticleId IdType="pmc">PMC8938795</ArticleId><ArticleId IdType="pubmed">35314653</ArticleId></ArticleIdList></Reference><Reference><Citation>Pievsky M. A., McGrath R. E. (2018). Neurocognitive effects of methylphenidate in adults with attention-deficit/hyperactivity disorder: A meta-analysis. Neuroscience and Biobehavioral Reviews, 90, 447&#x2013;455. 10.1016/j.neubiorev.2018.05.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2018.05.012</ArticleId><ArticleId IdType="pubmed">29751051</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran A. V., Jayadevan R., Sashidharan S. (2021). Long COVID: An overview. Diabetes &amp; Metabolic Syndrome, 15(3), 869&#x2013;875. 10.1016/j.dsx.2021.04.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>Riley D. S., Barber M. S., Kienle G. S., Aronson J. K., von Schoen-Angerer T., Tugwell P., Kiene H., Helfand M., Altman D. G., Sox H., Werthmann P. G., Moher D., Rison R. A., Shamseer L., Koch C. A., Sun G. H., Hanaway P., Sudak N. L., Kaszkin-Bettag M., . . . Gagnier J. J. (2017). CARE guidelines for case reports: Explanation and elaboration document. Journal of Clinical Epidemiology, 89, 218&#x2013;235. 10.1016/j.jclinepi.2017.04.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2017.04.026</ArticleId><ArticleId IdType="pubmed">28529185</ArticleId></ArticleIdList></Reference><Reference><Citation>Sartori A. C., Vance D. E., Slater L. Z., Crowe M. (2012). The impact of inflammation on cognitive function in older adults: Implications for healthcare practice and research. Journal of Neuroscience Nursing, 44(4), 206&#x2013;217. 10.1097/JNN.0b013e3182527690</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JNN.0b013e3182527690</ArticleId><ArticleId IdType="pmc">PMC3390758</ArticleId><ArticleId IdType="pubmed">22743812</ArticleId></ArticleIdList></Reference><Reference><Citation>Schou T. M., Joca S., Wegener G., Bay-Richter C. (2021). Psychiatric and neuropsychiatric sequelae of COVID-19 - A systematic review. Brain, Behavior, and Immunity, 97, 328&#x2013;348. 10.1016/j.bbi.2021.07.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.07.018</ArticleId><ArticleId IdType="pmc">PMC8363196</ArticleId><ArticleId IdType="pubmed">34339806</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Sillett R., Zhu L., Mendel J., Camplisson I., Dercon Q., Harrison P. J. (2022). Neurological and psychiatric risk trajectories after SARS-Cov-2 infection: An analysis of 2-year retrospective cohort studies including 1&#x2008;284&#x2008;437 patients. The Lancet Psychiatry, 9(10), 815&#x2013;827. 10.1016/s2215-0366(22)00260-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2215-0366(22)00260-7</ArticleId><ArticleId IdType="pmc">PMC9385200</ArticleId><ArticleId IdType="pubmed">35987197</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde M. W., Kim S. S., Lindsell C. J., Billig Rose E., Shapiro N. I., Files D. C., Gibbs K. W., Erickson H. L., Steingrub J. S., Smithline H. A., Gong M. N., Aboodi M. S., Exline M. C., Henning D. J., Wilson J. G., Khan A., Qadir N., Brown S. M., Peltan I. D., . . . Wu M. J.; IVY Network Investigators. (2020). Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a Multistate Health Care Systems Network &#x2014; United States, March&#x2013;June 2020. MMWR Morbidity and Mortality Weekly Report, 69(30), 993&#x2013;998. 10.15585/mmwr.mm6930e1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T. C., Cholevas C., Polyzoidis K., Politis A. (2021). Long-COVID syndrome-associated brain fog and chemofog: luteolin to the rescue. Biofactors, 47(2), 232&#x2013;241. 10.1002/biof.1726</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/biof.1726</ArticleId><ArticleId IdType="pmc">PMC8250989</ArticleId><ArticleId IdType="pubmed">33847020</ArticleId></ArticleIdList></Reference><Reference><Citation>Warren S., Drake J., Wu C. K. (2022). Cognitive complications of COVID-19 infection. Rhode Island Medical Journal, 105(7), 27&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">35930487</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>